On Wednesday, Ambev SA (ADR) (NYSE:ABEV)’s shares inclined 0.21% to $4.82.
ABEV is currently valued at $75.60 billion. The company has 14.70 billion shares outstanding. The company has 6.42 value in price to sale ratio while price to book ratio was recorded as -5.81. The company exchanged hands with 20.18 million shares as compared to its average daily volume of 18.14 million shares. It beta stands at 1.21. The mean estimate for the short term price target for Ambev SA (ADR) (NYSE:ABEV) stands at $5.37 according to 6 Analysts. The higher price target estimate for the stock has been calculated at $6.00 while the lower price target estimate is at $4.67. Ambev SA (ADR) (NYSE:ABEV) is a Brazil-based company engaged in the brewers sector. Ambev produces, distributes and sell beer, carbonated soft drinks (CSDs) and other non-alcoholic and non-carbonated products across the Americas.
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA)’s shares dropped -2.81% to $63.19.
TEVA offered -9.80% EPS for prior five years. The company has 7.70% return on equity value while its ROI ratio was 10.00%. The company has $62.27 billion market capitalizations and the institutional ownership was 56.70%. Its price to book ratio was 2.36. Volatility of the stock was 2.84% for the week while for the month booked as 2.72%. The mean estimate for the short term price target for Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) stands at $5.37 according to 6 Analysts. The higher price target estimate for the stock has been calculated at $6.00 while the lower price target estimate is at $4.67. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) is a global pharmaceutical and drug company. The Company’s generic products cover almost every major therapeutic area. The Company operates its business in two segments: Generic medicines, which manufactures and sells generic pharmaceutical products in several dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments and creams, and Specialty medicines, which delivers solutions to patients and providers via medicines, devices and services.
At the end of Wednesday’s trade, Danaher Corporation (NYSE:DHR)‘s shares dipped -0.69% to $95.98.
DHR has beta value of 1.19. The company has the market capitalization of $66.23 billion. Return on assets ratio of the company was 9.80% while its return on equity ratio was 16.60%. ATR value of company was 1.12 while stock volatility for week was 0.88% while for month was 1.08%. Debt to equity ratio of the company was -0.65 and its current ratio was 1.00. The mean estimate for the short term price target for Danaher Corporation (NYSE:DHR) stands at $100.68 according to 19 Analysts. The higher price target estimate for the stock has been calculated at $114.00 while the lower price target estimate is at $84.00. Danaher Corporation (NYSE:DHR) designs, manufactures and markets professional, medical, industrial and commercial products and services. It operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental, and Industrial Technologies.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.